Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
9328375 | Gynecologic Oncology | 2005 | 9 Pages |
Abstract
PEG3 silencing is associated with DNA hypermethylation but not gene deletion in cell lines tested. These results suggest that loss of PEG3 expression may be a frequent event in gynecologic cancers. Given the known role of PEG3 in p53-mediated apoptosis, it is possible that PEG3 functions as a tumor suppressor.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Sean C. Dowdy, Bobbie S. Gostout, Viji Shridhar, Xiaosheng Wu, David I. Smith, Karl C. Podratz, Shi-Wen Jiang,